[Health economic aspects of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]
- PMID: 15213879
- DOI: 10.1055/s-2004-826890
[Health economic aspects of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]
Comment on
-
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].Dtsch Med Wochenschr. 2004 Jan 2;129(1-2):13-8. doi: 10.1055/s-2004-812656. Dtsch Med Wochenschr. 2004. PMID: 14703575 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
